- Home
- Publications
- Publication Search
- Publication Details
Title
A network model for angiogenesis in ovarian cancer
Authors
Keywords
Network modeling, Gene regulation, Regulatory networks, Ovarian cancer, Cancer subtypes, Angiogenesis
Journal
BMC BIOINFORMATICS
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-04-11
DOI
10.1186/s12859-015-0551-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy
- (2015) Zoë Davison et al. NEOPLASIA
- Sigma 1 Receptor plays a prominent role in IL-24-induced cancer-specific apoptosis
- (2013) Winchie Do et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Predicting Response to Bevacizumab in Ovarian Cancer: A Panel of Potential Biomarkers Informing Treatment Selection
- (2013) F. Collinson et al. CLINICAL CANCER RESEARCH
- Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction
- (2013) P Storti et al. LEUKEMIA
- Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer
- (2013) Hao Zhang et al. PHYTOMEDICINE
- Passing Messages between Biological Networks to Refine Predicted Interactions
- (2013) Kimberly Glass et al. PLoS One
- Overexpression of myeloid zinc finger 1 suppresses matrix metalloproteinase-2 expression and reduces invasiveness of SiHa human cervical cancer cells
- (2012) Su-Ju Tsai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Combining Antiangiogenics to Overcome Resistance: Rationale and Clinical Experience
- (2012) V. Moreno Garcia et al. CLINICAL CANCER RESEARCH
- Developing New Drug Treatments in the Era of Network Medicine
- (2012) E K Silverman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Combinatorial Assembly of Developmental Stage-Specific Enhancers Controls Gene Expression Programs during Human Erythropoiesis
- (2012) Jian Xu et al. DEVELOPMENTAL CELL
- Targeting the Insulin Growth Factor Receptor 1
- (2012) Fernanda I. Arnaldez et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Antiangiogenic Agents in Combination With Chemotherapy for the Treatment of Epithelial Ovarian Cancer
- (2012) Deanna Teoh et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- (2012) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Dynamic Change of Chromatin Conformation in Response to Hypoxia Enhances the Expression of GLUT3 (SLC2A3) by Cooperative Interaction of Hypoxia-Inducible Factor 1 and KDM3A
- (2012) I. Mimura et al. MOLECULAR AND CELLULAR BIOLOGY
- Extracts of Lycoris aurea Induce Apoptosis in Murine Sarcoma S180 Cells
- (2012) Na Liao et al. MOLECULES
- Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
- (2012) Stefan Bentink et al. PLoS One
- A Natural Small Molecule Harmine Inhibits Angiogenesis and Suppresses Tumour Growth through Activation of p53 in Endothelial Cells
- (2012) Fujun Dai et al. PLoS One
- Identification of Cys255 in HIF-1α as a novel site for development of covalent inhibitors of HIF-1α/ARNT PasB domain protein-protein interaction
- (2012) Rosa Cardoso et al. PROTEIN SCIENCE
- BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site
- (2012) H J Kang et al. Cell Death & Disease
- Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
- (2012) Christine Madsen et al. Journal of Ovarian Research
- Molecular Predictors of Response to Antiangiogenesis Therapies
- (2011) Armin Gerger et al. CANCER JOURNAL
- Overview of anti-angiogenic agents in development for ovarian cancer
- (2011) Robert A. Burger GYNECOLOGIC ONCOLOGY
- The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer
- (2011) Ke-Jin Huang et al. MEDICAL ONCOLOGY
- The ARID Family Transcription Factor Bright Is Required for both Hematopoietic Stem Cell and B Lineage Development
- (2011) C. F. Webb et al. MOLECULAR AND CELLULAR BIOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of residues in the N-terminal PAS domains important for dimerization of Arnt and AhR
- (2011) Nan Hao et al. NUCLEIC ACIDS RESEARCH
- Dioxin exposure of human CD34+ hemopoietic cells induces gene expression modulation that recapitulates its in vivo clinical and biological effects
- (2011) Nicola Stefano Fracchiolla et al. TOXICOLOGY
- Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmol
- (2011) Mohamed A.M. El Gendy et al. TOXICOLOGY LETTERS
- Anti-angiogenic Agents in Ovarian Cancer: Dawn of a New Era?
- (2011) Joyce Liu et al. Current Oncology Reports
- Frozen robust multiarray analysis (fRMA)
- (2010) M. N. McCall et al. BIOSTATISTICS
- NF- B balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement
- (2010) A. B. Aurora et al. BLOOD
- An Atlas of Combinatorial Transcriptional Regulation in Mouse and Man
- (2010) Timothy Ravasi et al. CELL
- Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer
- (2010) N. Matsumura et al. GENOME RESEARCH
- Harman induces CYP1A1 enzyme through an aryl hydrocarbon receptor mechanism
- (2010) Mohamed A.M. El Gendy et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The selective aryl hydrocarbon receptor modulator 6-methyl-1,3,8-trichlorodibenzofuran inhibits prostate tumor metastasis in TRAMP mice
- (2009) Wayne A. Fritz et al. BIOCHEMICAL PHARMACOLOGY
- BioMart – biological queries made easy
- (2009) Damian Smedley et al. BMC GENOMICS
- Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
- (2009) N Murukesh et al. BRITISH JOURNAL OF CANCER
- Dioxin Receptor Deficiency Impairs Angiogenesis by a Mechanism Involving VEGF-A Depletion in the Endothelium and Transforming Growth Factor-β Overexpression in the Stroma
- (2009) Angel Carlos Roman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Furin/Proprotein Convertase-catalyzed Surface and Intracellular Processing by Small Molecules
- (2009) Tomoko Komiyama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
- (2009) Ursula A. Matulonis et al. JOURNAL OF CLINICAL ONCOLOGY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Biological Evaluation of Structurally Diverse Amaryllidaceae Alkaloids and their Synthetic Derivatives: Discovery of Novel Leads for Anticancer Drug Design
- (2009) Antonio Evidente et al. PLANTA MEDICA
- Artificial ligand binding within the HIF2 PAS-B domain of the HIF2 transcription factor
- (2009) T. H. Scheuermann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Divergent Transcriptomic Responses to Aryl Hydrocarbon Receptor Agonists between Rat and Human Primary Hepatocytes
- (2009) Erik A. Carlson et al. TOXICOLOGICAL SCIENCES
- Dioxin-induced toxicity on vascular remodeling of the placenta
- (2008) Ryuta Ishimura et al. BIOCHEMICAL PHARMACOLOGY
- The cell biology of DNA methylation in mammals
- (2008) Egor Prokhortchouk et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Gene set enrichment analysis using linear models and diagnostics
- (2008) Assaf P. Oron et al. BIOINFORMATICS
- Gene regulatory network inference: Data integration in dynamic models—A review
- (2008) Michael Hecker et al. BIOSYSTEMS
- Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression
- (2008) H. Schmidlin et al. BLOOD
- Antiangiogenic drugs in ovarian cancer
- (2008) G C Kumaran et al. BRITISH JOURNAL OF CANCER
- The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates
- (2008) Wayne A. Fritz et al. CARCINOGENESIS
- Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer
- (2008) S. X. Yang et al. CLINICAL CANCER RESEARCH
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Activation of theVEGFR1Chromatin Domain
- (2008) Debasree Dutta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Angiogenesis as a strategic target for ovarian cancer therapy
- (2008) Whitney A Spannuth et al. Nature clinical practice. Oncology
- Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?
- (2008) Cristiana Sessa et al. Nature clinical practice. Oncology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started